Open Surgery Instruments Market Report 2024

The open surgery instruments market size has grown strongly in recent years. It will grow from $60.61 billion in 2023 to $64.35 billion in 2024 at a compound annual growth rate (CAGR) of 6.2%. The growth observed in the historic period can be attributed to several factors, including the rise in surgical procedures due to advancing medical technologies and techniques, a growing aging population requiring more surgical interventions, expansion of healthcare infrastructure to support increasing healthcare needs, favorable regulatory environments facilitating healthcare advancements, rising healthcare expenditure to improve medical services, and an overall increase in the number of surgeries performed globally.

The open surgery instruments market size is expected to see strong growth in the next few years. It will grow to $82.25 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. In the forecast period, growth can be attributed to several factors, including the rise of personalized medicine tailored to individual patient needs, a high prevalence of chronic diseases necessitating surgical interventions, increased demand for advanced surgical equipment and technologies, expanding numbers of ambulatory surgical centers offering outpatient procedures, and growing adoption of laboratory automation to enhance efficiency and accuracy in diagnostics. Major trends expected in this period include advancements in laparoscopic instruments for minimally invasive surgeries, integration of imaging technologies such as intraoperative imaging and augmented reality for enhanced surgical precision, growth in the use of single-use surgical tools to minimize infection risks and improve efficiency, development of smart instruments equipped with sensor technology to monitor surgical parameters and enhance safety, and increasing adoption of energy-based devices for precise tissue cutting and hemostasis during surgeries.

The increasing prevalence of chronic diseases is poised to drive growth in the open surgery instrument market in the foreseeable future. Chronic diseases are persistent conditions that necessitate ongoing medical management and significantly impact individuals' quality of life. This rise in chronic diseases is influenced by various factors such as lifestyle changes, an aging population, improved healthcare accessibility, and genetic predispositions. Open surgery instruments play a crucial role in enhancing and optimizing the surgical treatment of chronic diseases. They enable healthcare providers to achieve greater procedural accuracy, reduce recovery times, and ensure patient safety and well-being during surgeries. For example, in 2024, the American Heart Association reported that cardiovascular disease led to 931,578 deaths in the US in 2021, slightly higher than the 928,741 deaths recorded in 2020. This underscores the driving force behind the open surgery instrument market, fueled by the need for effective management and treatment of chronic conditions.

Leading companies in the open surgery instrument market are actively developing advanced hybrid energy devices to enhance surgical safety and efficiency. These hybrid energy devices integrate multiple technologies to provide precise tissue control during surgical procedures, combining functions such as hemostatic cutting, coagulation, and dissection into a single instrument. This integration reduces the need for additional tools and instruments during surgeries, streamlining procedures and optimizing operating room efficiency. For instance, in September 2022, Olympus Corporation launched the THUNDERBEAT Open Fine Jaw Type X surgical energy product. It features a unique thermal shield that improves temperature management on the grabbing surface, thereby minimizing the risk of unintended heat damage to surrounding tissues, nerves, and structures. The THUNDERBEAT device utilizes both ultrasonic and bipolar energy to efficiently control tissue during both open and laparoscopic procedures, contributing to enhanced surgical outcomes and reduced procedure times.

In January 2024, Stille AB, a Sweden-based manufacturer of surgical instruments, acquired Fehling Instruments for $40.32 million. This strategic acquisition strengthens Stille AB's position as a leading provider of high-quality surgical instruments worldwide, enhancing their capability to support healthcare providers in improving surgical outcomes across various medical specialties. Through this acquisition, Stille AB expands its research and development capabilities and broadens its product portfolio. Fehling Instruments, based in Germany, is renowned for manufacturing premium-grade open surgical instruments.

Major companies operating in the open surgery instruments market are Johnson & Johnson Services Inc., Thermo Fisher Scientific Inc., Medtronic, Alcon, Olympus, Terumo Corporation, Intuitive Surgical, B. Braun Medical Ltd., Cook Medical, Teleflex Incorporated, Karl Storz, Mölnlycke Health Care AB, Integra LifeSciences Corporation, ConMed Corporation, C.R. Bard Inc., KLS Martin Group, Aspen Surgical Products Inc., Scanlan International Inc., Sklar Surgical Instruments, Grena Ltd., ELMED Incorporated.

North America was the largest region in the open surgery instruments market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the open surgery instruments market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the open surgery instruments market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Open surgeon instruments are specialized tools used in surgical procedures to access and operate on internal tissues and organs with precision and sterility. These instruments enable surgeons to perform diverse operations effectively and safely.

The main types of open surgery instruments include scalpels for precise incisions, scissors for cutting tissues, forceps and clamps for grasping and holding tissues, needles and sutures for wound closure, retractors for tissue exposure, suction devices for removing fluids, staplers and clips for tissue closure and hemostasis, energy systems for cutting and coagulation, and laparoscopic instruments for minimally invasive procedures. These instruments find application in various surgical specialties such as cardiothoracic surgery, urologic surgery, orthopedic surgery, and robot-assisted surgery. They are utilized across different healthcare settings including hospitals, ambulatory surgery centers, and clinics.

The open surgery instruments market research report is one of a series of new reports that provides Open surgery instruments market statistics, including the open surgery instruments industry global market size, regional shares, competitors with open surgery instruments market share, detailed open surgery instruments market segments, market trends, and opportunities, and any further data you may need to thrive in the open surgery instruments industry. These open surgery instruments market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The open surgery instruments market consists of sales of products such as hemostats, trocars, speculums, dilators, surgical sponges, surgical drapes, bone chisels, curettes, and surgical saws. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.